Search Menu Cart 0 €


Registration Restore password

EIA Borrelia garinii IgM (192)

EIA Borrelia garinii IgM (192)
EAN Code: 8595635302534
Catalog number: BgM192
Package size: 192 tests
Regulatory status: IVD CE
Storage: 2-8 °C
Producer: TestLine Clinical Diagnostics s.r.o.

Sample request

Sample ordering is possible only for registered users

If you are already registered, please log in
If you are new customer register

Contact person:

Name: MUDr. Jana Dočkalová
Phone: +420 549 121 205

The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia garinii infection using IgM antibodies in human serum, plasma, cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory.

If you are already registered, please login

Request Product Export to PDF Print

Have a question?
Need a help?

Do not hesitate and call us or fill in a query form and we will contact you soon.



·         Microtitre wells are coated with the sonicated whole-cell antigen of the Borrelia garinii rich in p83, p39, OspA, OspC, p41 and p100.

·         If specific antibodies are present, they bind to the antigen, are labeled by the Conjugate in the following steps and are detected by color reaction with a single component substrate (TMB-Complete).

·         The kit allows 192 tests, including controls in a split microtiter plate with color-coded strips and breakable wells.


·         The total assay time is about 1 hour 30 minutes.

·         High sensitivity and specificity of the test.

·         Kit includes CUT-OFF, Positive Control and Negative Control.

·         Semi-quantitative evaluation in the Index of Positivity (IP).

·         Ready-to-use, color-coded components.

·         Single-component substrate.

·         Interchangeable components with the exception of kit specific components (Controls, Conjugate, Plate).

·         Detection of intrathecal production of specific antibodies with the Antibody Index Software (made by TestLine).


·         Screening test for the detection of Lyme borreliosis in humans.

·         Checking of therapy results using the semiquantitative determination.

·         Improvement in diagnostic of neuroborreliosis by the detection of intrathecal production of specific antibodies to Borrelia sp.

Brief assay procedure:

1.       Dilute samples of serum/plasma (1:101), synovial fluid (1:21, 1:41) or cerebrospinal fluid (1:2).

2.       Pipette Controls and diluted Samples.

3.       Incubate at 37°C for 30 min.

4.       Aspirate and wash the wells 5×

5.       Pipette Conjugate.

6.       Incubate at 37°C for 30 min.

7.       Aspirate and wash the wells 5×

8.       Pipette Substrate (TMB-Complete).

9.       Incubate at 37°C for 15 min.

10.   Pipette Stop Solution.

11.   Read color intensity at 450 nm.

12.   Evaluate the test.